Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Research and development	$ 21,076	$ 25,055
General and administrative	6,462	8,707
Total operating expenses	27,538	33,762
Loss from operations	(27,538)	(33,762)
Other income, net:
Interest income	635	1,452
Other income, net	39	82
Total other income, net	674	1,534
Net loss before income tax expense	(26,864)	(32,228)
Net loss	(26,864)	(32,228)
Other comprehensive loss:
Net unrealized loss on marketable securities	(38)	(14)
Comprehensive loss	$ (26,902)	$ (32,242)
Net loss per share, basic	$ (0.24)	$ (0.40)
Net loss per share, diluted	$ (0.24)	$ (0.40)
Weighted-average shares used in computing net loss per share, basic	109,869,278	80,982,326
Weighted-average shares used in computing net loss per share, diluted	109,869,278	80,982,326